medicines that are substrates with the CYP3A enzyme as they may possibly develop into fewer effective during treatment method with JOURNAVX. Your healthcare provider may have to regulate the dose of the medicine when beginning or stopping JOURNAVXThese compounds interact with our endocannabinoid procedure. This conversation contributes to a lot of